RxDoctor Payments Data

Brandi Morinoue, PA

Physician Assistant · Irvine, CANPI 1184652778

Payments from drug & device makers

$1,443in general payments, 2019–2025

Across 47 payments — averaging $30.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$589
  • AbbVie$317
  • Galderma Laboratories, L.p.$125
  • Cleerly, Inc.$123
  • Sanofi-aventis U.S. LLC$58
  • Menarini Silicon Biosystems, Inc.$48
  • plus $182 from 6 others

What the payments were for

  • Food & beverage$1,443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,443 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$55,176
Medicare patients
164
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$46,764
SynthroidLevothyroxine Sodium29$2,619
Estradiol13$2,207
ValacyclovirValacyclovir Hcl23$1,866
Np ThyroidThyroid,pork42$1,689
ProgesteroneProgesterone, Micronized35$1,328
Armour ThyroidThyroid,pork15$997
Liothyronine Sodium26$978
Hydroxychloroquine Sulfate56$920
Testosterone Cypionate11$783
Bupropion XlBupropion Hcl30$467
Spironolactone24$397
Levothyroxine Sodium59$366
Lisinopril28$359
Metformin Hcl64$342

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid, Armour Thyroid$317$3,61644 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Irvine

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →